Ad19a-HERV-K ISDmut

N/A

Report date: 2025/03/14 16:23:58

Base Information

Drug NameAd19a-HERV-K ISDmut
Drug Alias Nameadenovirus vector vaccine targeting HERV-K (University of Copenhagen/InProTher/Sirion Biotech)virus like vaccine targeting human endogenous retrovirus K (University of Copenhagen/InProTher/Sirion Biotech)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsProstatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Copenhagen
China Registration ClassN/A

Develop Information

Active CompaniesSirion Biotech International IncHERVOLUTION Therapeutics APSUniversity Of Copenhagen
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A